In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice
Open Access
- 1 August 1990
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (8), 1467-1472
- https://doi.org/10.1128/aac.34.8.1467
Abstract
The in vivo effects of antimicrobial agents against Toxoplasma gondii were evaluated in mice that were infected intraperitoneally with 10(4) tachyzoites of the RH strain by determination of survival rates and study of the kinetics of growth of T. gondii in infected mice. At various intervals after infection, subcultures of serial dilutions of blood, lung, and brain homogenates were performed in fibroblast tissue cultures for determination of parasitic loads. Pyrimethamine (18.5 mg/kg per day), sulfadiazine (375 mg/kg per day), and clindamycin (300 mg/kg per day) were administered for 10 days from day 1 or day 4 after infection. Untreated control mice died within 9 days and showed early and predominant lung involvement. All mice treated with sulfadiazine administered from day 1 survived and were apparently healthy; parasitic loads decreased early after treatment, but a relapse was observed 5 days after the cessation of therapy. When pyrimethamine was administered from day 1, 7 of 11 mice died within 25 days; by determination of parasitic loads, the effect of pyrimethamine was only demonstrable from day 6, and a relapse was constantly observed after the cessation of therapy. When pyrimethamine and sulfadiazine were administered in combination, 100% of mice survived; when therapy was started at day 1, parasites remained undetectable; in mice treated from day 4, parasites were eradicated by day 8 but infection relapsed 8 days after the cessation of therapy. All mice treated with clindamycin from day 1 or day 4 died within 10 days, but parasitemia was always undetectable. These results indicate that study of the kinetics of parasitic loads in blood and organs may provide additional information on the effect of antimicrobial agents against T. gondii in regard to the evolution of the infection and may represent a reliable basis for the determination of therapeutic regimens in humans.Keywords
This publication has 13 references indexed in Scilit:
- In vitro effects of folate inhibitors on Toxoplasma gondiiAntimicrobial Agents and Chemotherapy, 1989
- Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice.The Journal of Immunology, 1989
- INVITRO ASSESSMENT OF MACROLIDES, LINCOSAMIDES AND SYNERGESTINES ON TOXOPLASMA-GONDII1988
- Potent Effect of Trimetrexate, a Lipid-Soluble Antifolate, on Toxoplasma gondiiThe Journal of Infectious Diseases, 1987
- Clindamycin in a murine model of toxoplasmic encephalitisAntimicrobial Agents and Chemotherapy, 1987
- Murine Model of Intracerebral ToxoplasmosisThe Journal of Infectious Diseases, 1987
- Pyrimethamine pharmacokinetics and its tissue localization in mice: effect of dose sizeJournal of Pharmacy and Pharmacology, 1985
- Strain-dependent, route of challenge-dependent, murine susceptibility to toxoplasmosisZeitschrift für Parasitenkunde, 1984
- Effect of Clindamycin on Acute and Chronic Toxoplasmosis in MiceAntimicrobial Agents and Chemotherapy, 1974
- Comparative Toxicological, Chemotherapeutic and Pharmacokinetic Studies with Sulphormethoxine and other Sulphonamides in Animals and ManChemotherapy, 1969